Gefitinib Qilu

Gefitinib Qilu is an oral medication used to target specific proteins in cancer cells. It is commonly prescribed for certain types of lung cancer and may help slow the progression of the disease.

Gefitinib Qilu is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often considered when the cancer has specific EGFR mutations.

Common effects of Gefitinib Qilu may include skin rash, diarrhea, and dry skin. Some individuals might also experience nausea, vomiting, or loss of appetite. These effects can vary in severity and may not affect everyone who takes the medication.

Gefitinib Qilu should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication may not be suitable for everyone, especially those with certain medical conditions or allergies.

Gefitinib Qilu may interact with other medications, including certain antibiotics, antifungals, and seizure medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect how the body processes Gefitinib.